GLOBUS MEDICAL INC
GMEDAPI behind this page
GMED FY 2025 request
Playground key active
/api/financials?ticker=GMED&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 2,938,931 | 2,519,355 | +16.7% |
Show Product Lines breakouts |
|||
| Enabling Technologies | 141,008 | 154,003 | -8.4% |
| Musculoskeletal Solutions | 2,797,923 | 2,365,352 | +18.3% |
Show Business Segments breakouts |
|||
| Reportable Segment | 2,938,931 | 2,519,354 | +16.7% |
Show Geography breakouts |
|||
| Non Us | 571,335 | 519,288 | +10.0% |
| US | 2,367,596 | 2,000,067 | +18.4% |
| Cost of Revenue | 957,802 | 1,035,479 | -7.5% |
Show Business Segments breakouts |
|||
| Reportable Segment | 819,124 | 719,160 | +13.9% |
| Research & Development | 147,246 | 163,754 | -10.1% |
| Selling, General & Administrative | 1,178,498 | 981,362 | +20.1% |
| Amortization Of Intangible Assets | 118,194 | 119,373 | -1.0% |
Show Business Segments breakouts |
|||
| Reportable Segment | 118,194 | 119,373 | -1.0% |
| Business Combination Acquisition Related Costs | 42,326 | 29,623 | +42.9% |
Show Business Segments breakouts |
|||
| Reportable Segment | 42,326 | 29,623 | +42.9% |
| Restructuring Costs | 15,049 | 23,773 | -36.7% |
| Operating Income | 479,816 | 165,991 | +189.1% |
Show Business Segments breakouts |
|||
| Reportable Segment | 483,229 | 168,196 | +187.3% |
| Interest Income Expense Nonoperating Net | 7,141 | -4,189 | +270.5% |
Show Business Segments breakouts |
|||
| Reportable Segment | 7,141 | -4,189 | +270.5% |
| Foreign Currency Transaction Gain Loss Before Tax | -3,006 | -43,285 | +93.1% |
Show Business Segments breakouts |
|||
| Reportable Segment | -3,006 | -43,285 | +93.1% |
| Business Combination Bargain Purchase Gain Recognized Amount | 117,704 | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | 117,704 | — | — |
Show Restatement breakouts |
|||
| Restatement Adjustment · Nevro Merger Agreement | 7,143 | — | — |
Show Business Acquisition breakouts |
|||
| Nevro Merger Agreement | 117,704 | — | — |
| Other Non-Operating Income (Expense) | 3,413 | 2,205 | +54.8% |
| Non-Operating Income (Expense) | 125,252 | -45,269 | +376.7% |
| Income Before Taxes | 605,068 | 120,722 | +401.2% |
Show Business Segments breakouts |
|||
| Reportable Segment | 605,068 | 120,722 | +401.2% |
| Income Tax Expense (Benefit) | 67,200 | 17,738 | +278.8% |
| Net Income | 537,868 | 102,984 | +422.3% |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 448 | 1,545 | -71.0% |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | 21,759 | 1,786 | +1118.3% |
| Other Comprehensive Income | 22,207 | 3,331 | +566.7% |
Show Equity Components breakouts |
|||
| Accumulated Net Unrealized Investment Gain Loss | 448 | 1,545 | -71.0% |
| Accumulated Translation Adjustment | 21,759 | 1,786 | +1118.3% |
| Comprehensive Income | 560,075 | 106,315 | +426.8% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 22,207 | 3,331 | +566.7% |
| Retained Earnings | 537,868 | 102,984 | +422.3% |
| EPS (Basic) | 3.98 | 0.76 | +423.7% |
| EPS (Diluted) | 3.92 | 0.75 | +422.7% |
| Wtd Avg Shares (Basic) | 135,215 | 135,726 | -0.4% |
| Wtd Avg Shares (Diluted) | 137,056 | 137,863 | -0.6% |
| Net Income Loss Available To Common Stockholders Basic | 537,868 | 102,984 | +422.3% |
| Labor And Related Expense (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | -891,617 | -763,188 | -16.8% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 526,156 | 784,438 | -32.9% |
| Marketable Securities (Current) | 31,087 | 105,619 | -70.6% |
| Accounts Receivable | 678,938 | 557,697 | +21.7% |
| Inventory | 759,277 | 659,233 | +15.2% |
| Prepaid Expenses & Other Current Assets | 65,426 | 49,640 | +31.8% |
| Income Taxes Receivable | 64,727 | 20,633 | +213.7% |
| Total Current Assets | 2,125,611 | 2,177,260 | -2.4% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 564,452 | 561,909 | +0.5% |
| Operating Lease Right-of-Use Assets | 63,786 | 49,647 | +28.5% |
| Marketable Securities (Non-Current) | 71,819 | 66,134 | +8.6% |
| Goodwill | 1,435,033 | 1,432,387 | +0.2% |
| Other Non-Current Assets | 78,781 | 75,096 | +4.9% |
| Deferred Tax Assets | 218,215 | 94,200 | +131.7% |
| Total Assets | 5,302,761 | 5,251,750 | +1.0% |
| Intangible Assets | 745,064 | 795,117 | -6.3% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 250,483 | 266,467 | -6.0% |
| Developed Technology Rights | 477,139 | 523,588 | -8.9% |
| Patents | 8,334 | 3,966 | +110.1% |
| Trade Names | 9,108 | 1,096 | +731.0% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 745,064 | 795,117 | -6.3% |
| Current Liabilities | |||
| Accounts Payable | 98,852 | 75,118 | +31.6% |
| Accrued Liabilities | 333,586 | 260,591 | +28.0% |
| Operating Lease Liability Current | 14,738 | 10,249 | +43.8% |
| Accrued Income Taxes Current | 4,155 | 10,725 | -61.3% |
| Business Acquisition Liabilities Current | 19,513 | 33,739 | -42.2% |
| Deferred Revenue (Current) | 27,655 | 22,140 | +24.9% |
| Total Current Liabilities | 498,499 | 855,913 | -41.8% |
| Non-Current Liabilities | |||
| Business Acquisition Liabilities Noncurrent | 81,995 | 89,496 | -8.4% |
| Operating Lease Liabilities | 103,918 | 83,588 | +24.3% |
| Deferred Income Taxes And Other Tax Liabilities Noncurrent | 23,756 | 23,889 | -0.6% |
| Other Non-Current Liabilities | 21,343 | 21,531 | -0.9% |
| Total Liabilities | 729,511 | 1,074,417 | -32.1% |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show Statement Class Of Stock breakouts |
|||
| Common Class A | 113 | 115 | -1.7% |
| Common Class B | 22 | 22 | 0.0% |
| Additional Paid-In Capital | 3,169,812 | 3,031,244 | +4.6% |
| Accumulated Other Comprehensive Income | 15,346 | -6,861 | +323.7% |
| Retained Earnings | 1,387,957 | 1,152,813 | +20.4% |
| Total Stockholders' Equity | 4,573,250 | 4,177,333 | +9.5% |
Show Equity Components breakouts |
|||
| Accumulated Net Unrealized Investment Gain Loss | 131 | -317 | +141.3% |
| Accumulated Other Comprehensive Income | 15,346 | -6,861 | +323.7% |
| Accumulated Translation Adjustment | 15,215 | -6,544 | +332.5% |
| Additional Paid In Capital | 3,169,812 | 3,031,244 | +4.6% |
| Common Stock · Common Class A | 113 | 115 | -1.7% |
| Common Stock · Common Class B | 22 | 22 | 0.0% |
| Retained Earnings | 1,387,957 | 1,152,813 | +20.4% |
| Total Liabilities & Equity | 5,302,761 | 5,251,750 | +1.0% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 276,842 | 253,389 | +9.3% |
| Inventory Write Down | 22,119 | 23,359 | -5.3% |
| Amortization Of Acquisition Accounting Fair Value Step Up | 26,112 | 242,050 | -89.2% |
Show Business Segments breakouts |
|||
| Reportable Segment | 19,455 | 215,420 | -91.0% |
Show Business Acquisition breakouts |
|||
| Nevro Merger Agreement | 19.3 | — | — |
| Stock-Based Compensation | 49,779 | 54,191 | -8.1% |
| Provision For Doubtful Accounts | 10,223 | 16,986 | -39.8% |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 13,462 | 26,521 | -49.2% |
| Deferred Income Taxes And Tax Credits | 18,625 | -125,902 | +114.8% |
| Gain Loss On Disposition Of Assets1 | 12,525 | 5,552 | +125.6% |
| Payment For Contingent Consideration Liability Operating Activities | -17,018 | -18,763 | +9.3% |
| Net Gain Loss From Foreign Currency Adjustment | -12,591 | 25,212 | -149.9% |
| Change in Accounts Receivable | -52,182 | -78,062 | +33.2% |
| Change in Inventory | -17,598 | -29,860 | +41.1% |
| Change in Prepaid & Other Assets | 11,132 | 1,059 | +951.2% |
| Change in Accounts Payable | 8,487 | 17,663 | -52.0% |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 34,217 | 5,023 | +581.2% |
| Increase Decrease In Accrued Income Taxes Payable | -50,851 | -13,377 | -280.1% |
| Net Cash from Operations | 753,447 | 520,638 | +44.7% |
| Investing Activities | |||
| Payments To Acquire Marketable Securities | -107,531 | -113,504 | +5.3% |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 63,880 | 58,666 | +8.9% |
| Proceeds From Sale Of Available For Sale Securities Debt | 115,608 | 11,851 | +875.5% |
| Capital Expenditures | -164,679 | -115,429 | -42.7% |
| Payments To Acquire Businesses Net Of Cash Acquired | -252,546 | -17,635 | -1332.1% |
| Payments To Acquire Intangible Assets | -9,746 | — | — |
| Net Cash from Investing | -355,014 | -176,051 | -101.7% |
| Financing Activities | |||
| Payment Of Business Acquisition Liabilities | -15,572 | -45,619 | +65.9% |
| Proceeds From Stock Options Exercised | 89,757 | 110,439 | -18.7% |
| Tax Withholding for Share Compensation | -2,909 | -6,729 | +56.8% |
| Share Repurchases | -300,451 | -85,787 | -250.2% |
| Repayments Of Senior Debt | -449,985 | — | — |
| Net Cash from Financing | -679,160 | -27,696 | -2352.2% |
| Supplemental | |||
| Income Taxes Paid | 98,916 | 158,508 | -37.6% |
| Unpaid Capital Expenditures | 13,454 | 9,281 | +45.0% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 22,445 | 255 | +8702.0% |
| Net Change in Cash | -258,282 | 317,146 | -181.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 526,156 | 784,438 | -32.9% |
| Income Tax Paid Federal After Refund Received | 65,374 | — | — |
| Income Tax Paid State And Local After Refund Received | 9,281 | — | — |
| Income Tax Paid Foreign After Refund Received (FY) | — | — | — |
Show Income Tax Authority breakouts |
|||
| AU | 9,996 | — | — |
| Foreign Country | 24,261 | — | — |
| Foreign Tax Jurisdiction Other | 14,265 | — | — |
Values in thousands USD. Source: SEC EDGAR 10-K filing.